Needham Raises Vicor Price Target to $400 Despite Valuation Risks and Insider Selling

Needham’s $400 price target implies about 20.71% upside from the stock’s then-current price, and MarketBeat data cited in the coverage put Vicor’s consensus price target at $245 with an overall average rating of “Buy.”
Alongside the Needham raise, other analysts’ moves were detailed: Zacks upgraded Vicor from “hold” to “strong-buy” (Feb. 23), Roth Mkm reaffirmed “buy” with a $245 target (Apr. 20), Weiss Ratings reiterated “hold (c+)” (June 1), and Wall Street Zen cut Vicor from “buy” to “hold” (Apr. 25).
Vicor’s quarterly results included specific profitability and earnings beats: EPS of $0.44 versus $0.40 consensus (up year over year), revenue of $112.97 million versus $109.05 million consensus, with return on equity of 20.21% and net margin of 28.98%. Analysts also projected 2.71 EPS for the current fiscal year.
The reporting also broke out particular insider sales: VP Claudio Tuozzolo sold 730 shares at an average price of $292.89 (June 11), and CEO Patrizio Vinciarelli sold 50,000 shares in a transaction dated Apr. 15 (the report notes the sale but truncates the average sale price details).
Needham & Company analyst N. Quinn Bolton raised his price target on Vicor (NASDAQ: VICR) to $400 on Monday, up from $350, while keeping a "Buy" rating on the stock, according to WatchlistNews. The new target implies about 20.71% upside from where shares were trading at the time of the call.
The move came just days after VICR hit an all-time high of $363.00 on June 18, according to Investing.com Canada. Craig-Hallum also moved on the same day, maintaining its own "Buy" rating and lifting its target even higher — to $450 — per GuruFocus.
Bolton's bullish call centers on Vicor's "Vertical Power Delivery" (VPD) technology. VPD solves a critical problem: AI chips need enormous amounts of current that traditional power systems cannot handle. Needham's $400 target is built on a 50x multiple of its projected 2028 EPS of $8.00, according to Investing.com.
Other analysts have also grown more confident. GuruFocus reported that Roth Capital raised its price target from $285 to $375, a 31.58% jump, while keeping a "Buy" rating. Earlier, on February 23, Zacks upgraded Vicor from "Hold" to "Strong-Buy," citing early signs of demand growth in AI infrastructure.
Vicor's Q1 2026 results gave analysts plenty to cheer about. The company posted EPS of $0.44, beating the $0.40 consensus. Revenue came in at $112.97 million, topping the $109.05 million estimate. Net margin was 28.98% and return on equity hit 20.21%, according to MarketBeat.
Year-over-year, the earnings picture was dramatic. EPS jumped from $0.06 in Q1 2025 to $0.44 in Q1 2026 — a 633% increase. The company's backlog surged 70% to $300.6 million. Then in May, Vicor raised its Q2 revenue guidance from $126 million to $142 million after signing a new patent license deal with a major OEM, per Investing.com.
Not everyone is buying the rally. GuruFocus flags Vicor as "Significantly Overvalued," with its GF Value estimate sitting at just $62.88 — roughly 80% below the current stock price. The stock trades at a trailing P/E of 110.83x and a price-to-sales ratio of 32.24x. That is more than double the industry median.
Insider selling adds to the cautionary picture. CEO Patrizio Vinciarelli sold 50,000 shares on April 15 under a pre-scheduled 10b5-1 plan. Quiver Quantitative data shows he has liquidated roughly $116.8 million in shares over the past six months. On June 11, VP Claudio Tuozzolo also sold 730 shares at an average price of $292.89, according to Investing.com.
At its June 19 annual shareholder meeting in Boston, Vicor management unveiled a revised long-term financial model. The company is targeting $2.5 billion in revenue and 70% gross margins — up from 55.2% in Q1 2026. Vicor is also working to open a second chip fabrication facility to meet demand, per Investing.com.
The road is not without risk. Vicor is sampling next-generation VPD products for AI chip startup Cerebras, with a production ramp expected in Q1 2027. But with the stock "priced for perfection" at current levels, any delay in converting its $300.6 million backlog into shipped product could trigger a sharp correction, analysts on Seeking Alpha warn.
Publishers
12
Articles
7
Reach
19